FDA Device Intelligence
HomeQUIDEL CORPORATION › AmpliVue

AmpliVue

QUIDEL CORPORATION · Model C. difficile Assay · UDI-DI 30014613312017

OZN Prescription
10
510(k) clearances
31
Adverse events
8
Recalls
13
Facilities

Description

AmpliVue CDiff Assay

Recalls

DateFirmReason
2025-12-05Meridian Bioscience IncThe affected lots show a decline in performance over time, which may lead to false-negative results.
2025-09-23Becton Dickinson & Co.Product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product service credentials ar
2024-10-31Becton Dickinson & Co.BD confirmed that product service credentials used by some BD technical support teams to access certain BD products were accessed by an unauthorized actor. Until these product serv
2023-06-05Luminex CorporationIt is possible that in rare instances the VERIGENE CDF Nucleic Acid Test Kit (Part No. 20-005-022) and the VERIGENE Enteric Pathogens Nucleic Acid Test Kit (Part No. 20-005-023) co
2022-06-17Luminex CorporationThere is a potential for false negative results using VERIGENE CDF Stool PREP KIT and VERIGENE EP Stool PREP KIT due to hydrophobic characteristics of the swab.
2019-02-20Luminex CorporationThrough internal investigation, it was discovered that a portion of side cassette assemblies (SCAs) back side seal (BSS) did not meet design specification, resulting in partially
2013-10-16Nanosphere, Inc.Nanosphere has received report of an increased rate of "No Call - INT CTL 2" results for the Internal Control 2 (INT CTL 2) when negative samples are tested with certain lots of CD
2013-10-10Nanosphere, Inc.Nanosphere has received several reports relating to an increased rate of Processing Errors during procedures performed on the Processor SP caused by Tips in Tip Holder Assemblies f

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.